Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Pharmacological Blockade of ERG K+ Channels and Ca2+ Influx through Store-Operated Channels Exerts Opposite Effects on Intracellular Ca2+ Oscillations in Pituitary GH3 Cells

Agnese Secondo, Maurizio Taglialatela, Mauro Cataldi, Giovanna Giorgio, Monica Valore, Gianfranco Di Renzo and Lucio Annunziato
Molecular Pharmacology November 2000, 58 (5) 1115-1128; DOI: https://doi.org/10.1124/mol.58.5.1115
Agnese Secondo
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maurizio Taglialatela
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauro Cataldi
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanna Giorgio
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Valore
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gianfranco Di Renzo
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucio Annunziato
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In the present study, the effects on intracellular calcium concentration ([Ca2+]i) oscillations of the blockade of ether-a-go-go-related gene (ERG) K+channels and of Ca2+ influx through store-operated channels (SOC) activated by [Ca2+]i store depletion have been studied in GH3 cells by means of a combination of single-cell fura-2 microfluorimetry and whole-cell mode of the patch-clamp technique. Nanomolar concentrations (1–30 nM) of the piperidinic second-generation antihistamines terfenadine and astemizole and of the class III antiarrhythmic methanesulfonanilide dofetilide, by blocking ERG K+ channels, increased the frequency and the amplitude of [Ca2+]i oscillations in resting oscillating GH3 cells. These compounds also induced the appearance of an oscillatory pattern of [Ca2+]i in a subpopulation of nonoscillating GH3 cells. The effects of ERG K+ channel blockade on [Ca2+]i oscillations appeared to be due to the activation of L-type Ca2+ channels, because they were prevented by 300 nM nimodipine. By contrast, the piperazinic second-generation antihistamine cetirizine (0.01–30 μM), which served as a negative control, failed to affect ERG K+channels and did not interfere with [Ca2+]ioscillations in GH3 cells. Interestingly, micromolar concentrations of terfenadine and astemizole (0.3–30 μM), but not of dofetilide (10–100 μM), produced an inhibition of the spontaneous oscillatory pattern of [Ca2+]i changes. This effect was possibly related to an inhibition of SOC, because these compounds inhibited the increase of [Ca2+]iachieved by extracellular calcium reintroduction after intracellular calcium store depletion with the sarcoplasmic or endoplasmic reticulum calcium ATPase pump inhibitor thapsigargin (10 μM) in an extracellular calcium-free medium. The same inhibitory effect on [Ca2+]i oscillations and SOC was observed with the first-generation antihistamine hydroxyzine (1–30 μM), the more hydrophobic metabolic precursor of cetirizine. Collectively, the results of the present study obtained with compounds that interfere in a different concentration range with ERG K+ channels or SOC suggest that 1) ERG K+ channels play a relevant role in controlling the oscillatory pattern of [Ca2+]i in resting GH3 cells and 2) the inhibition of SOC might induce an opposite effect, i.e., an inhibition of [Ca2+]i oscillations.

Footnotes

    • Received February 18, 2000.
    • Accepted August 9, 2000.
  • Send reprint requests to: Dr. Lucio Annunziato, M.D., Unit of Pharmacology, Department of Neurosciences, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy. E-mail:lannunzi{at}unina.it

  • The study was supported by the following grants: Telethon 1058, National Research Council 97.04512. CT04, 97.01230. PF49, and 98.03149. CT04 (M.T.); Istituto Superiore di Sanità, Roma, Italy (Progetto sulle proprietà chimico-fisiche dei medicamenti e loro sicurezza d' uso), National Research Council 96.02074, 97.04559, 98.01048. CT04, and 98.00062. PF31 (PS Biotecnologie 5%), Murst Cofinanziamento 1998, and Regione Campania (P.O.P. and Legge 41) (L.A.).

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 58 (5)
Molecular Pharmacology
Vol. 58, Issue 5
1 Nov 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacological Blockade of ERG K+ Channels and Ca2+ Influx through Store-Operated Channels Exerts Opposite Effects on Intracellular Ca2+ Oscillations in Pituitary GH3 Cells
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Pharmacological Blockade of ERG K+ Channels and Ca2+ Influx through Store-Operated Channels Exerts Opposite Effects on Intracellular Ca2+ Oscillations in Pituitary GH3 Cells

Agnese Secondo, Maurizio Taglialatela, Mauro Cataldi, Giovanna Giorgio, Monica Valore, Gianfranco Di Renzo and Lucio Annunziato
Molecular Pharmacology November 1, 2000, 58 (5) 1115-1128; DOI: https://doi.org/10.1124/mol.58.5.1115

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Pharmacological Blockade of ERG K+ Channels and Ca2+ Influx through Store-Operated Channels Exerts Opposite Effects on Intracellular Ca2+ Oscillations in Pituitary GH3 Cells

Agnese Secondo, Maurizio Taglialatela, Mauro Cataldi, Giovanna Giorgio, Monica Valore, Gianfranco Di Renzo and Lucio Annunziato
Molecular Pharmacology November 1, 2000, 58 (5) 1115-1128; DOI: https://doi.org/10.1124/mol.58.5.1115
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Relapsed-Leukemia Model with NT5C2/PRPS1 Hotspot Mutations
  • The Binding Site for KCI807 in the Androgen Receptor
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics